TeleTrader 11.03.2016 European stocks rally with confidence
TeleTrader 29.02.2016 Denmark: GDP up 0.20%, unemployment rate at 3.70%
TeleTrader 25.02.2016 European markets end higher on earnings
TeleTrader 22.02.2016 European markets jump-start trading week
TeleTrader 25.01.2016 European markets close lower, pressured by oil
GlobeNewswire 29.09.2015 Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
GlobeNewswire 14.09.2015 Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study
GlobeNewswire 14.08.2015 Ossur Hf : Share Options Granted
GlobeNewswire 27.03.2015 Bavarian Nordic A/S - Notice Convening Ordinary General Meeting
GlobeNewswire 26.03.2015 NNIT A/S: 13/2015 Stabilisation period ends
GlobeNewswire 19.03.2015 Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide)
GlobeNewswire 13.03.2015 Bavarian Nordic A/S - Major Shareholder Announcement
GlobeNewswire 11.03.2015 Bavarian Nordic Announces 2014 Full Year Results
GlobeNewswire 24.02.2015 Bavarian Nordic Announces Updated Overall Survival Data from Combination Immunotherapy Data of PROST...
GlobeNewswire 27.01.2015 Bavarian Nordic A/S - Major Shareholder Announcement
GlobeNewswire 06.01.2015 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-...
GlobeNewswire 10.12.2014 Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC® in Prostate Canc...
GlobeNewswire 04.12.2014 Bavarian Nordic Announces First Subject Dosed with MVA-BN® Filo in a Phase 1 Study Investigating a N...
GlobeNewswire 18.11.2014 Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants
GlobeNewswire 13.11.2014 Bavarian Nordic Announces Interim Results for the First Nine Months of 2014
GlobeNewswire 06.11.2014 Bavarian Nordic to Host Third Quarter 2014 Results Conference Call
GlobeNewswire 29.10.2014 Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson &...
GlobeNewswire 22.10.2014 Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN® for Additional Infectious D...
GlobeNewswire 22.10.2014 Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Dev...
GlobeNewswire 22.10.2014 Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine